Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronit Almog

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|May 27, 2005
Statins and the risk of colorectal cancerJenny N Poynter, Stephen B Gruber, Peter D R Higgins, et al.
JMIR Medical Informatics|March 5, 2020
Analyzing Medical Research Results Based on Synthetic Data and Their Relation to Real Data Results: Systematic Comparison From Five Observational StudiesAnat Reiner Benaim, Ronit Almog, Yuri Gorelik, et al.
Asian Journal of Surgery|April 16, 2020
Robotic inguinal hernia repair: Is it a new era in the management of inguinal hernia?Eli Kakiashvili, Maxim Bez, Ibrahim Abu Shakra, et al.
Cancer Discovery|September 3, 2021
Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid TumorsIthai Waldhorn, Roy Holland, Tal Goshen-Lago, et al.
Antibodies (Basel, Switzerland)|August 27, 2024
Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster DoseAvi Magid, Khetam Hussein, Halima Dabaja-Younis, et al.
Vaccines|October 27, 2022
Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare WorkersKhetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, et al.
JAMA Oncology|July 8, 2021
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for CancerTal Goshen-Lago, Ithai Waldhorn, Roy Holland, et al.
The American Journal of Surgical Pathology|April 30, 2003
Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instabilityJoel K Greenson, Joseph D Bonner, Ofer Ben-Yzhak, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 28, 2021
Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in IsraelYael Shachor-Meyouhas, Khetam Hussein, Halima Dabaja-Younis, et al.
Vaccines|February 28, 2023
Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care WorkersYael Shachor-Meyouhas, Halima Dabaja-Younis, Avi Magid, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|May 27, 2005
Statins and the risk of colorectal cancerJenny N Poynter, Stephen B Gruber, Peter D R Higgins, et al.
JMIR Medical Informatics|March 5, 2020
Analyzing Medical Research Results Based on Synthetic Data and Their Relation to Real Data Results: Systematic Comparison From Five Observational StudiesAnat Reiner Benaim, Ronit Almog, Yuri Gorelik, et al.
Asian Journal of Surgery|April 16, 2020
Robotic inguinal hernia repair: Is it a new era in the management of inguinal hernia?Eli Kakiashvili, Maxim Bez, Ibrahim Abu Shakra, et al.
Cancer Discovery|September 3, 2021
Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid TumorsIthai Waldhorn, Roy Holland, Tal Goshen-Lago, et al.
Antibodies (Basel, Switzerland)|August 27, 2024
Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster DoseAvi Magid, Khetam Hussein, Halima Dabaja-Younis, et al.
Vaccines|October 27, 2022
Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare WorkersKhetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, et al.
JAMA Oncology|July 8, 2021
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for CancerTal Goshen-Lago, Ithai Waldhorn, Roy Holland, et al.
The American Journal of Surgical Pathology|April 30, 2003
Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instabilityJoel K Greenson, Joseph D Bonner, Ofer Ben-Yzhak, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 28, 2021
Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in IsraelYael Shachor-Meyouhas, Khetam Hussein, Halima Dabaja-Younis, et al.
Vaccines|February 28, 2023
Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care WorkersYael Shachor-Meyouhas, Halima Dabaja-Younis, Avi Magid, et al.
Pageof 6